Found: 13
Select item for more details and to access through your institution.
1479. Clinical Efficacy and Safety Analysis Evaluating Oral Gepotidacin (GSK2140944) from a Phase IIa Study in the Treatment of Uncomplicated Urinary Tract Infections.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S539, doi. 10.1093/ofid/ofz360.1343
- By:
- Publication type:
- Article
1480. Plasma and Urine Pharmacokinetic Analysis of Gepotidacin (GSK2140944) Following BID Oral Dosing in a Phase IIa Study for Treatment of Uncomplicated Urinary Tract Infections.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S539, doi. 10.1093/ofid/ofz360.1344
- By:
- Publication type:
- Article
1482. Microbiological Analysis from a Phase II Study Evaluating Gepotidacin (GSK2140944) in the Treatment of Uncomplicated Urinary Tract Infections.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S540, doi. 10.1093/ofid/ofz360.1346
- By:
- Publication type:
- Article
Design of Two Phase III, Randomized, Multicenter Studies Comparing Gepotidacin with Nitrofurantoin for the Treatment of Uncomplicated Urinary Tract Infection in Female Participants.
- Published in:
- Infectious Diseases & Therapy, 2022, v. 11, n. 6, p. 2297, doi. 10.1007/s40121-022-00706-9
- By:
- Publication type:
- Article
Pharmacokinetics of Gepotidacin in Renal Impairment.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 5, p. 560, doi. 10.1002/cpdd.807
- By:
- Publication type:
- Article
Pharmacokinetics, Safety, and Tolerability Evaluation of Single and Multiple Doses of GSK3342830 in Healthy Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 6, p. 754, doi. 10.1002/cpdd.637
- By:
- Publication type:
- Article
Book reviews.
- Published in:
- 2003
- By:
- Publication type:
- Book Review
Self-Reported quality of life in adults with attention-deficit/hyperactivity disorder and executive function impairment treated with lisdexamfetamine dimesylate: a randomized, double-blind, multicenter, placebo-controlled, parallel-group study.
- Published in:
- BMC Psychiatry, 2013, v. 13, n. 1, p. 107, doi. 10.1186/1471-244X-13-253
- By:
- Publication type:
- Article
Gepotidacin for the Treatment of Uncomplicated Urogenital Gonorrhea: A Phase 2, Randomized, Dose-Ranging, Single-Oral Dose Evaluation.
- Published in:
- Clinical Infectious Diseases, 2018, v. 67, n. 4, p. 504, doi. 10.1093/cid/ciy145
- By:
- Publication type:
- Article
Safety and tolerability of lifitegrast ophthalmic solution 5.0%: Pooled analysis of five randomized controlled trials in dry eye disease.
- Published in:
- European Journal of Ophthalmology, 2019, v. 29, n. 4, p. 394, doi. 10.1177/1120672118791936
- By:
- Publication type:
- Article
Measuring Agreement Between Two Raters for Ordinal Response: a Model-based Approach.
- Published in:
- Journal of the Royal Statistical Society: Series D (The Statistician), 1999, v. 48, n. 3, p. 339, doi. 10.1111/1467-9884.00192
- By:
- Publication type:
- Article
Ocular comfort assessment of lifitegrast ophthalmic solution 5.0% in OPUS-3, a Phase III randomized controlled trial.
- Published in:
- Clinical Ophthalmology, 2018, v. 12, p. 263, doi. 10.2147/OPTH.S152841
- By:
- Publication type:
- Article
Gepotidacin is efficacious in a nonhuman primate model of pneumonic plague.
- Published in:
- Science Translational Medicine, 2022, v. 14, n. 647, p. 1, doi. 10.1126/scitranslmed.abg1787
- By:
- Publication type:
- Article